序号 |
标题 |
次数 |
作者 |
发布时间 |
271 |
cas:1260247-50-4,DADPS Biotin Azide,抗体药物偶联物(ADC) |
4 |
kx |
2024-12-20 |
272 |
Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2OH-Fmoc |
7 |
h |
2024-12-20 |
273 |
MC-vc-PAB-Tubulysin M-ADC Linker |
4 |
zyl |
2024-12-20 |
274 |
CAS: 2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH |
4 |
WYQ |
2024-12-20 |
275 |
cas:2055198-09-7,3-Azidopropionic Acid Sulfo-NHS ester, ADC试剂 |
4 |
kx |
2024-12-20 |
276 |
Lys-psi(CH2NH)-Trp(Nps)-OMe |
4 |
h |
2024-12-20 |
277 |
刺五加苷B脂质体,Eleutheroside,B,liposomes,EB-LP |
5 |
axc |
2024-12-20 |
278 |
CAS: 2055024-63-8,NH2-PEG1-Val-Cit-PAB-OH |
5 |
WYQ |
2024-12-20 |
279 |
CH2COOH-PEG3-CH2COOH |
4 |
wyh |
2024-12-20 |
280 |
Fmoc-N-PEG-CH2COOH (MW 5000) |
4 |
h |
2024-12-20 |
281 |
cas:2086689-02-1,2-(Biotin-amido)-1,3-bis(carboxylethoxy)propane,抗体药物偶联物(ADC) |
5 |
kx |
2024-12-20 |
282 |
MAC-VC-PABC-ST7612AA1 |
5 |
zyl |
2024-12-20 |
283 |
CAS: 2055024-57-0,Fmoc-PEG6-Val-Cit-PAB-OH |
5 |
WYQ |
2024-12-20 |
284 |
异戊酰紫草素脂质体,Isovalerylshikonin-liposome,Iso,SHK-lip,定制服务 |
5 |
axc |
2024-12-20 |
285 |
Azido-PEG2-CH2COOH (CHA) |
7 |
h |
2024-12-20 |
286 |
HO-PEG-CH2COOH (MW 3400) |
6 |
h |
2024-12-20 |
287 |
cas:1400191-52-7,DBCO-Sulfo-NHS ester, ADC试剂 |
6 |
kx |
2024-12-20 |
288 |
CAS: 2249935-92-8,Mal-PEG1-Val-Cit-PAB-PNP |
3 |
WYQ |
2024-12-20 |
289 |
MC-Val-Cit-PAB-rifabutin cas:2055900-34-8 |
5 |
zyl |
2024-12-20 |
290 |
Amine-PEG-CH2COOH (MW 3400) |
5 |
h |
2024-12-20 |
291 |
CAS: 2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH |
4 |
WYQ |
2024-12-20 |
292 |
PEG6-(CH2CO2H)2 |
4 |
h |
2024-12-20 |
293 |
cas:173414-89-6,bis(2,5-dioxopyrrolidin-1-yl) 3,3’-(2-((3-(2,5-dioxopyrrolidin-1-yloxy)-3-oxopropoxy)methyl)-2-methylpropane-1,3-diyl)bis(oxy)dipropanoate |
6 |
kx |
2024-12-20 |
294 |
HOOC-PEtOx(50)-Pip,α-羧甲基-聚(2-乙基-2-恶唑啉)-ω-哌啶,HOOC-CH2(C5H9NO)50NC6H12 |
3 |
wyh |
2024-12-20 |
295 |
CAS: 2055041-38-6,Mal-PEG2-Val-Cit-PAB-OH |
4 |
WYQ |
2024-12-20 |
296 |
水杨酸脂质体可溶性微针(SA-LIP-DMNs),定制服务 |
4 |
axc |
2024-12-20 |
297 |
Boc-Aminooxy-PEG4-CH2CO2H |
3 |
h |
2024-12-20 |
298 |
MC-Val-Cit-PAB-Auristatin E cas:2055896-77-8 |
5 |
zyl |
2024-12-20 |
299 |
cas:1245813-70-0,tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate |
4 |
kx |
2024-12-20 |
300 |
鼠尾草酸脂质体,LP-CA,定制服务 |
3 |
axc |
2024-12-20 |
301 |
Boc-L-Phe(4-CH2-N3)-OH,205127-59-9,Boc-L-苯丙氨酸(4-氨基甲基-叠氮)-羟基 |
5 |
wyh |
2024-12-20 |
302 |
Fmoc-PEG4-Val-Cit-PAB-OH, CAS号:2055024-58-1 |
5 |
WYQ |
2024-12-20 |
303 |
HOOCCH2O-PEG4-CH2COOH |
6 |
h |
2024-12-20 |
304 |
Fmoc-PEG2-Val-Cit-PAB-OH,CAS号:2055024-59-2 |
5 |
WYQ |
2024-12-20 |
305 |
BnO-PEG1-CH2CO2tBu |
4 |
h |
2024-12-20 |
306 |
cas:824426-32-6,Azidoacetic acid NHS ester,叠氮乙酸 NHS 酯, ADC试剂 |
4 |
kx |
2024-12-20 |
307 |
Boc-NH-(CH2)15-COOH , 135747-73-8 |
5 |
wyh |
2024-12-20 |
308 |
Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
3 |
WYQ |
2024-12-20 |
309 |
t-Butyl acetate-PEG3-CH2COOH |
4 |
h |
2024-12-20 |
310 |
鼠尾草酸转铁蛋白结合脂质体,Tf-LP-CA,定制服务 |
3 |
axc |
2024-12-20 |
311 |
Cbz-NH-PEG10-CH2COOH |
4 |
h |
2024-12-20 |
312 |
cas:2182601-80-3,Azido-PEG8-CH2CO2-PFP |
3 |
wyh |
2024-12-20 |
313 |
CAS: 2746391-62-6 MAL-di-EG-Val-Cit-PAB-MMAE |
5 |
zyl |
2024-12-20 |
314 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate,ADC定制 |
3 |
kx |
2024-12-20 |
315 |
CAS: 2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH |
4 |
WYQ |
2024-12-20 |